Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- Check6 days agoChange DetectedOnly a revision label update was made (v3.3.2 added, v3.3.1 removed) and no study information or page features were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedA new revision entry v3.3.1 was added to the history, and the entry for v3.2.0 was removed.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the top banner notice regarding government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check35 days agoChange DetectedThe two screenshots show minor visual and layout updates to the page header, navigation, and footer, with no changes to the record history content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference11%

- Check71 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content now reflects the newer release identifier; other substantive content remains unchanged.SummaryDifference0.3%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.